A field guide to reading drug data.
The codes, classes and label sections you'll see on every product page, and how to read them.
The National Drug Code
Every drug product listed with the FDA carries a unique 10-digit, three-segment NDC. The first segment is assigned by the FDA to the labeler (the company that manufactures, repackages or distributes the product). The labeler assigns the other two: the product code identifies strength, dosage form and formulation; the package code identifies size and type.
0169-4404-31
- 01Labeler code
- Novo Nordisk
- 02Product code
- Wegovy (semaglutide) 4 mg tablet
- 03Package code
- Bottle of 30 tablets
Segments come in three configurations — 4-4-2, 5-3-2 and 5-4-1 — which is why NDCs look inconsistent across products. Billing systems normalise them to eleven digits (5-4-2) by adding a leading zero to the short segment.
NDC inside the UPC
A drug's UPC-A barcode embeds the 10-digit NDC between a leading 3 (the number system reserved for drugs) and a trailing check digit. So 0354092387014 contains NDC 54092-387-01.
Strength & units
Strengths are written as an amount per unit: 4 mg/1 means four milligrams per one dosage unit (a tablet or capsule), while 2.68 mg/mL is a concentration. Combination products list each active ingredient separately.
Pharmacologic classes
The FDA tags each active ingredient with up to four kinds of class, drawn from the NDF-RT and MeSH vocabularies:
- Established Pharmacologic Class [EPC]
- The clinically meaningful grouping, e.g. GLP-1 Receptor Agonist.
- Mechanism of Action [MoA]
- The molecular interaction, e.g. Glucagon-like Peptide-1 Agonists.
- Physiologic Effect [PE]
- The effect on the body, e.g. Central Nervous System Stimulation.
- Chemical Structure [CS]
- The structural family, e.g. Glucagon-Like Peptide 1.
Anatomy of a label
Prescription labels in the Physician Labeling Rule format run in a fixed order: boxed warning, indications, dosage, dosage forms and strengths, contraindications, warnings, adverse reactions, interactions, specific populations, abuse and dependence, overdosage, description, clinical pharmacology, nonclinical toxicology, clinical studies, how supplied, and patient counselling.
For how a drug works, section 12 — Clinical Pharmacology — is the one to read: 12.1 Mechanism of Action, 12.2 Pharmacodynamics and 12.3 Pharmacokinetics (absorption, distribution, metabolism, excretion). Each product page collects these under its Pharmacology tab.
DEA schedules
Controlled substances are placed in schedules by abuse potential and accepted medical use. You'll see these in the catalog:
- CII
- High potential for abuse; accepted medical use. Amphetamine, methylphenidate, lisdexamfetamine.
- CIII
- Moderate potential. Buprenorphine, anabolic steroids including testosterone.
- CIV
- Lower potential. Phentermine.
Approval pathways
The marketing category shows how a product reached the market. NDA and BLA are full applications for new drugs and biologics — the brands. ANDA is the abbreviated pathway for generics, which must show bioequivalence to the reference product. NDA authorized generic is the brand's own product sold under its generic name.